Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1644629-23-1

Post Buying Request

1644629-23-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1644629-23-1 Usage

Molecular structure

1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine has a complex molecular structure consisting of a pyrrolopyridine core and a boron-containing dioxaborolane group.

Pyrrolopyridine core

The molecule features a pyrrolopyridine core, which is a five-membered ring containing two nitrogen atoms, contributing to its unique chemical properties.

Dioxaborolane group

A boron-containing dioxaborolane group is attached to the pyrrolopyridine core, which consists of a five-membered ring with two oxygen atoms and a boron atom.

Boron atom reactivity

The boron atom in the dioxaborolane group can be used as a site for further chemical reactions, making the compound a versatile building block for synthetic chemistry.

Methyl group contributions

Methyl groups are attached to both the boron and the pyrrolopyridine ring, contributing to the molecule's stability and hydrophobicity.

Potential applications

Due to its unique structure and reactivity, 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine may have potential applications in various fields, such as medicinal chemistry, materials science, and organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 1644629-23-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,4,4,6,2 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1644629-23:
(9*1)+(8*6)+(7*4)+(6*4)+(5*6)+(4*2)+(3*9)+(2*2)+(1*3)=181
181 % 10 = 1
So 1644629-23-1 is a valid CAS Registry Number.

1644629-23-1Downstream Products

1644629-23-1Relevant articles and documents

HPK1 ANTAGONISTS AND USES THEREOF

-

, (2021/03/19)

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1644629-23-1